Mirae Asset Global Etfs Holdings Ltd. Harvard Bioscience Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,151 shares of HBIO stock, worth $58,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,151Holding current value
$58,799% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
102Shares Held
32MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$7.91 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.71 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.11 Million0.9% of portfolio
-
Amh Equity LTD2.2MShares$6.12 Million8.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.89 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $116M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...